After introduction of vaccination, some prevalences of nonvaccine types changed, without clear evidence for type replacement
BACKGROUND: The new nine-valent vaccine against human papillomavirus (HPV) includes the four HPV ge...
Human papillomavirus (HPV) has been identified as the main etiological factor in the developing of c...
Background.Little is known about type-specific associations between prevalent human papillomavirus (...
We analyzed human papillomavirus (HPV) prevalences during prevaccination and postvaccination periods...
We analyzed human papillomavirus (HPV) prevalences during prevaccination and postvaccination periods...
We analyzed human papillomavirus (HPV) prevalences during prevaccination and postvaccination periods...
Examination of cross-protection and type replacement after human papillomavirus (HPV) vaccine introd...
Efficacy of human papillomavirus (HPV) vaccines promises to control HPV infections. However, HPV vac...
Millions of women have been vaccinated with one of two first-generation human papillomavirus (HPV) v...
Human papillomavirus (HPV) is detected in 99.7% of cervical cancers. Current vaccines target types 1...
Millions of women have been vaccinated with one of two first-generation human papillomavirus (HPV) v...
Efficacy of human papillomavirus (HPV) vaccines promises to control HPV infections. However, HPV vac...
Background: Although human papillomavirus (HPV) vaccines are highly efficacious in protecting agains...
Oncogenic non-vaccine human papillomavirus (HPV) types may conceivably fill the vacated ecological n...
Background: Although human papillomavirus (HPV) vaccines are highly efficacious in protecting agains...
BACKGROUND: The new nine-valent vaccine against human papillomavirus (HPV) includes the four HPV ge...
Human papillomavirus (HPV) has been identified as the main etiological factor in the developing of c...
Background.Little is known about type-specific associations between prevalent human papillomavirus (...
We analyzed human papillomavirus (HPV) prevalences during prevaccination and postvaccination periods...
We analyzed human papillomavirus (HPV) prevalences during prevaccination and postvaccination periods...
We analyzed human papillomavirus (HPV) prevalences during prevaccination and postvaccination periods...
Examination of cross-protection and type replacement after human papillomavirus (HPV) vaccine introd...
Efficacy of human papillomavirus (HPV) vaccines promises to control HPV infections. However, HPV vac...
Millions of women have been vaccinated with one of two first-generation human papillomavirus (HPV) v...
Human papillomavirus (HPV) is detected in 99.7% of cervical cancers. Current vaccines target types 1...
Millions of women have been vaccinated with one of two first-generation human papillomavirus (HPV) v...
Efficacy of human papillomavirus (HPV) vaccines promises to control HPV infections. However, HPV vac...
Background: Although human papillomavirus (HPV) vaccines are highly efficacious in protecting agains...
Oncogenic non-vaccine human papillomavirus (HPV) types may conceivably fill the vacated ecological n...
Background: Although human papillomavirus (HPV) vaccines are highly efficacious in protecting agains...
BACKGROUND: The new nine-valent vaccine against human papillomavirus (HPV) includes the four HPV ge...
Human papillomavirus (HPV) has been identified as the main etiological factor in the developing of c...
Background.Little is known about type-specific associations between prevalent human papillomavirus (...